Condition
Papulopustular Rosacea clinical trials and research
Research outlook What's coming for Rosacea: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Papulopustular Rosacea clinical trials that are recruiting, at sites in 9 countries (most in United States (2), Bulgaria (1), Canada (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 9Countries
All recruiting trials (2)
-
Remibrutinib for moderate-to-severe papulopustular rosacea
A Phase 2 study tests whether remibrutinib can reduce inflammatory facial lesions in adults with moderate-to-severe papulopustular rosacea.
-
Topical Clascoterone Cream for Treating Acneiform Rosacea
This study is testing if a new cream can help people with acne-like rosacea by reducing the size of the oil glands in their skin.
Related topics
Quick answers
How many Papulopustular Rosacea clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (2 trials), Bulgaria (1 trial), Canada (1 trial), China (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.